Healthcare Reimbursement Market Report

Global Healthcare Reimbursement Market Size

The global healthcare reimbursement market was valued at USD 24.95 billion in 2025. The global healthcare reimbursement market size is forecasted to be worth USD 99.69 billion by 2034 from USD 29.1 billion in 2026, growing at a CAGR of 16.64% from 2026 to 2034.

Healthcare reimbursement is the process by which private health insurers or government agencies pay for the services of healthcare providers. Healthcare reimbursement plans are sometimes referred to as healthcare reimbursement arrangements to distinguish them from traditional employer-sponsored health insurance plans. COVID-19 introduces new reimbursement challenges in the healthcare industry, such as billing and coding and patient financial accountability, and this trend will continue to threaten healthcare organizations in 2021. The trend toward digitalization and payment automation was driven by new processes triggered by a significant decrease in face-to-face interaction and a rapid increase in telehealth check-ups. Having the right technologies and best practices in place will significantly aid in ensuring both billing compliance and reimbursement maximization in the future.

MARKET DRIVERS

The growing awareness among people regarding the importance of health insurance policies and healthcare coverage is majorly propelling the global healthcare reimbursement market growth.

A health insurance policy is a contract between an insurance company and a policyholder in which the insurer pays for the life insured's medical expenses. This policy applies to services reported using the 1500 Health Insurance Claim Form (a/k/a CMS-1500) or its electronic equivalent or successor form. This policy applies to all products, all network and non-network physicians, and other qualified health care professionals, including, but not limited to, non-network authorized and percent of charge contract physicians and other qualified health care professionals.

Growing costs of the federal and state governments' operation of the Medicare and Medicaid programs are expected to accelerate the growth rate of the global healthcare reimbursement market during the forecast period.

Medicaid has become the primary source of medical and health-related services in the United States for low-income and resource-constrained Americans. In 2019, Medicaid accounted for 16% of total healthcare spending in the United States. The federal and state governments play a role in the program's success. Medicaid spending increased in recent years as the percentage of people on Medicaid increased. The Medicare program cost the United States approximately $800 billion in 2019.

Growing primary healthcare worldwide is predicted to promote the global healthcare reimbursement market growth.

According to WHO & PHC, nearly 930 million people worldwide are at risk of falling into poverty due to out-of-pocket health spending of 10% or more of their household budget. Achieving the PHC targets will necessitate an additional investment of between $200 and 370 billion USD per year for a more comprehensive package of health services. By 2030, expanding primary health care (PHC) interventions in low and middle-income countries could save 60 million lives and increase average life expectancy by 3.7 years. PHC is the most inclusive, equitable, cost-effective, and efficient method of improving people's physical and mental health, as well as their social well-being.

Additionally, advancements in EMR technology for monitoring patient responsiveness, rising digital technology advancements in healthcare, growing initiatives from the public and private sectors, and rising healthcare costs are expected to favor the global healthcare reimbursement market. The growing geriatric population worldwide, increasing prevalence of chronic diseases, and rising government investments are further estimated to boost the market growth during the forecast period.

MARKET RESTRAINTS

Deterioration in the quality of care available to patients in need of high-cost treatments, as well as the administrative burden that clinicians frequently face. The high number of incidents involving fraudulent activities for state and government-led health programs is expected to limit the global healthcare reimbursement market growth. Complications exist in the market as a core feature of a complex framework. The risk of patient data breaches or HIPAA violations is expected to further limit the market growth.

REPORT COVERAGE

KEY MARKET PLAYERS

Companies are currently playing a dominating role in the global healthcare reimbursement market.

• CVS Health
• UnitedHealth Group
• Nippon Life Insurance
• Allianz
• WellCare Health Plans
• Aviva Life Insurance Company India Ltd.
• AgileHealthInsurance
• Aetna
• Blue Cross Blue Shield Association
• Aetna Inc. (duplicate of Aetna)
• Reliance BNP Paribas

MARKET SEGMENTATION

This research report on the global healthcare reimbursement market has been segmented and sub-segmented based on the claims, payer, service provider & region.

By Claims

• Underpaid
• Full Paid

By Payer

• Private Payers
• Public Payers

By Service Provider

• Physician Office
• Hospitals
• Diagnostic Laboratories
• Others

By Region

• North America
• Europe
• Asia-Pacific
• Latin America
• The Middle East and Africa